Last viewed: JAZZ

Prices are updated after-hours

JAZZ Nasdaq

Jazz Pharmaceuticals plc

JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

(0.0% 1d) (-14.2% 1m) (-26.1% 1y) (0.0% 2d) (0.0% 3d) (-3.4% 7d) (8.63% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 6,927,480,000
http://www.jazzpharma.com
Sec Filling | Patents | 1620 employees

(IE) Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

urea narcolepsy msa

Drugs

DEFITELIO (defibrotide sodium)
ERWINAZE (Asparaginase)
FazaClo (clozapine)
Prialt (ziconotide)
SUNOSI (solriamfetol)
VYXEOS ((daunorubicin and cytarabine) liposome)
Xyrem (sodium oxybate)
XYWAV ((calcium, magnesium, potassium, and sodium oxybates))
ZEPZELCA (Lurbinectedin)

add to watch list Paper trade email alert is off

Press-releases

Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Published: 2024-04-17 (Crawled : 23:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -1.65% | O: 0.13% H: 0.2% C: -1.78%
first report pharmaceuticals financial results

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K

|

Health Technology

| -10.96% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -2.16% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K

|

| -10.79% | O: -0.29% H: 0.0% C: -1.97%
VTRS A | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -5.12% | O: -0.6% H: 1.03% C: 0.52%
TMO | News | $544.78 0.6% 0.0% 1.7M

|

Health Technology

| -9.54% | O: -2.01% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -2.71% | O: -1.16% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -7.38% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -7.38% | O: -1.71% H: 0.57% C: 0.37%
pharmaceuticals meeting

AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING
Published: 2024-03-28 (Crawled : 13:00) - prnewswire.com
MS | News | $90.66 0.44% 0.07% 8.1M

|

| -3.02% | O: 0.27% H: 1.05% C: 0.44%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -11.13% | O: 0.0% H: 0.85% C: -0.07%
first million pharmaceuticals

Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
Published: 2024-03-12 (Crawled : 22:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -8.17% | O: -0.44% H: 0.59% C: -0.28%
day pharmaceuticals

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-06 (Crawled : 21:00) - globenewswire.com
ZYME | $8.85 2.08% 2.03% 550K

|

Health Technology

| -27.64% | O: -6.93% H: 9.65% C: 0.51%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -8.61% | O: -0.12% H: 0.41% C: -0.58%
BGNE | $129.51 -1.86% -1.89% 300K

|

Health Technology

| -15.97% | O: -0.93% H: 3.2% C: 2.66%
year financial results

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
Published: 2024-02-28 (Crawled : 21:00) - prnewswire.com
ZYME | $8.85 2.08% 2.03% 550K

|

Health Technology

| -26.62% | O: 1.82% H: 1.47% C: -2.2%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -17.42% | O: -3.24% H: 0.0% C: -5.26%
year pharmaceuticals financial results

Medical marijuana market size to grow at a CAGR of 21.86% from 2022 to 2027, The rising number of product launches drives market growth, Technavio
Published: 2024-02-28 (Crawled : 11:00) - prnewswire.com
ACB | News | $6.46 -1.15% -1.16% 6.2M

|

Process Industries

| 96.71% | O: -1.8% H: 3.66% C: -1.52%
OGI | $1.94 -5.37% -5.67% 2M

|

Process Industries

| 0.93% | O: -0.93% H: 0.0% C: -4.21%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -19.02% | O: -0.06% H: 0.51% C: -1.88%
CRON | News | $2.37 -1.66% -1.69% 3.9M

|

Process Industries

| 17.39% | O: 0.43% H: 0.43% C: -2.16%
medical market

Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
ASOMY | $4.35 9.57% 6K

|

| -10.99% | O: 1.58% H: 0.85% C: 0.41%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -19.33% | O: 0.32% H: 0.12% C: -0.71%
ICLR | $288.32 -1.2% -1.21% 640K

|

Health Technology

| -8.38% | O: 0.02% H: 1.56% C: 1.15%
pharmaceuticals

Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
Published: 2024-02-21 (Crawled : 21:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

|

Health Technology

| -0.65% | O: -2.33% H: 1.55% C: 1.06%
JAZZ | $109.96 0.63% 0.63% 760K

|

Health Technology

| -15.24% | O: -0.12% H: 1.79% C: 1.75%
pharmaceuticals financial

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001765581-24-000038	4	2024-03-08	2024-03-07	Sell	S	1768	6596
0001765581-24-000038	4	2024-03-08	2024-03-06	Sell	S	700	8364
0001765581-24-000038	4	2024-03-08	2024-03-06	Sell	S	1236	9064
0001765581-24-000036	4	2024-03-08	2024-03-05	Sell	F	3622	57093
0001765581-24-000035	4	2024-03-08	2024-03-05	Sell	F	2474	16922
0001765581-24-000033	4	2024-03-08	2024-03-05	Sell	F	3432	41629
0001765581-24-000031	4	2024-03-08	2024-03-05	Sell	F	4294	62226

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

RXO P 200000 | $19.37 2.32% 0.0% 1M

|

| 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M

|

| 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K

|

Health Technology

| 22:30
BCDA P 2750 | $0.377 -1.4% 97K

|

Health Technology

| 22:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar